Abstract: This application relates to imidazolone compounds, pharmaceutically acceptable salts, solvents, polymorphs or prodrugs thereof, and further relates to pharmaceutical combinations comprising the foregoing substances and uses for preventing and treating protein kinase related diseases such as cancer, metabolic diseases, and cardiovascular diseases.
Type:
Grant
Filed:
November 14, 2014
Date of Patent:
August 14, 2018
Assignee:
BEIJING FORELANDPHARMA CO. LTD.
Inventors:
Xingmin Zhang, Qi Ji, Lei Wang, Congmin Gao, Ensi Wang, Zhenjian Du, Longlong Gong, Bo Chen
Abstract: This application relates to imidazolone compounds, pharmaceutically acceptable salts, solvents, polymorphs or prodrugs thereof, and further relates to pharmaceutical combinations comprising the foregoing substances and uses for preventing and treating protein kinase related diseases such as cancer, metabolic diseases, and cardiovascular diseases.
Type:
Application
Filed:
November 14, 2014
Publication date:
October 20, 2016
Applicant:
BEIJING FORELANDPHARMA CO. LTD.
Inventors:
Xingmin ZHANG, Qi JI, Lei WANG, Congmin GAO, Ensi WANG, Zhenjian DU, Longlong GONG, Bo CHEN